PARP1 and stroke disorder: Therefore, PARP inhibitors are likely to be multipotent in stroke by (1) blocking programmed neuronal necrosis in a large portion of neurons, (2) attenuating the early pro-inflammation response that is thought to be accelerated by reperfusion, and (3) protecting the endothelium and limiting hemorrhagic transformation that is thought to be augmented during aging.